POSTER: MM-304 Efficacy Outcomes and Characteristics of Patients With Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity After Treatment With Ciltacabtagene Autoleucel (cilta-cel) in CARTITUDE-1

Clinical Lymphoma, Myeloma & Leukemia(2023)

引用 0|浏览3
暂无评分
关键词
multiple myeloma,ciltacabtagene autoleucel,residual disease,cilta-cel
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要